Hammersmith Medicines Research Ltd

(HMR) is a Contract Research Organisation (CRO) specializing in clinical pharmacology, phase 1, and early phase 2 trials. With of spacious premises equipped with , a sleep unit for polysomnography, volunteer facilities, laboratories, pharmacy including an aseptic unit and radiopharmacy, and offices, HMR offers a full-service for early-phase studies. Their team of over , including , , and , has conducted since . As one of the largest early-phase CROs in Europe, HMR operates in the , , and industries. Their most recent funding of was received from on .